1. Home
  2. LTRX vs MDWD Comparison

LTRX vs MDWD Comparison

Compare LTRX & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LTRX
  • MDWD
  • Stock Information
  • Founded
  • LTRX 1989
  • MDWD 2000
  • Country
  • LTRX United States
  • MDWD Israel
  • Employees
  • LTRX N/A
  • MDWD N/A
  • Industry
  • LTRX Computer Communications Equipment
  • MDWD Medicinal Chemicals and Botanical Products
  • Sector
  • LTRX Telecommunications
  • MDWD Health Care
  • Exchange
  • LTRX Nasdaq
  • MDWD Nasdaq
  • Market Cap
  • LTRX 199.5M
  • MDWD 235.7M
  • IPO Year
  • LTRX 2000
  • MDWD 2014
  • Fundamental
  • Price
  • LTRX $5.00
  • MDWD $18.00
  • Analyst Decision
  • LTRX Strong Buy
  • MDWD Strong Buy
  • Analyst Count
  • LTRX 3
  • MDWD 2
  • Target Price
  • LTRX $5.17
  • MDWD $37.50
  • AVG Volume (30 Days)
  • LTRX 249.6K
  • MDWD 67.3K
  • Earning Date
  • LTRX 11-05-2025
  • MDWD 11-20-2025
  • Dividend Yield
  • LTRX N/A
  • MDWD N/A
  • EPS Growth
  • LTRX N/A
  • MDWD N/A
  • EPS
  • LTRX N/A
  • MDWD N/A
  • Revenue
  • LTRX $118,294,000.00
  • MDWD $20,932,000.00
  • Revenue This Year
  • LTRX $4.77
  • MDWD $21.39
  • Revenue Next Year
  • LTRX $11.90
  • MDWD $23.01
  • P/E Ratio
  • LTRX N/A
  • MDWD N/A
  • Revenue Growth
  • LTRX N/A
  • MDWD 6.15
  • 52 Week Low
  • LTRX $1.91
  • MDWD $14.14
  • 52 Week High
  • LTRX $5.74
  • MDWD $22.51
  • Technical
  • Relative Strength Index (RSI)
  • LTRX 54.17
  • MDWD 49.48
  • Support Level
  • LTRX $4.45
  • MDWD $16.66
  • Resistance Level
  • LTRX $4.88
  • MDWD $18.62
  • Average True Range (ATR)
  • LTRX 0.26
  • MDWD 0.70
  • MACD
  • LTRX 0.00
  • MDWD -0.02
  • Stochastic Oscillator
  • LTRX 55.88
  • MDWD 59.56

About LTRX Lantronix Inc.

Lantronix Inc is a networking company. It provides secure data access and management solutions for the Internet of Things (IoT) and information technology assets. It organizes its products and solutions into three product lines: Embedded IoT Solutions, IoT Systems Solutions, and Software and Services. The IoT System Solutions segment is the key revenue driver for the company. The company serves a diverse range of markets including healthcare, industrial, security, energy, transportation, and government networking. Its primary geographic markets are the Americas, Europe, the Middle East and Africa, and Asia Pacific Japan. The Americas contribute the vast majority of total revenue.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: